Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Toronto

$25,000.00

Phage display validation of custom biosurface coated microplates

FY 2011-12

Summary
Antibodies are a natural defense mechanism of animals to foreign proteins entering a body. They are specific to each protein and can be used in medicine to disable proteins of interest in order to treat a variety of diseases including cancer. Traditionally, antibodies to a specific protein have been isolated by injecting animals with the protein of interest and allowing the animal's natural immune system to create antibodies that are recovered by researchers. This can prove cumbersome with little guarantee of recovering a functional antibody; indeed, numerous proteins fail to illicit a functional antibody after months of work for a variety of reasons. In order to circumvent these difficulties we have employed a technology called phage display that uses bacteria to make synthetic antibodies. Once isolated, we can further strengthen the binding and/or specificity of the antibodies to the selected target (protein), a technique not possible with traditional antibody discovery methods. Phage display, in its fastest and most facile form, requires immobilization of the protein onto a plastic surface before incubation of the protein with a library of antibodies. In order for the isolated antibody to recognize the protein within the body, however, the protein must fold on the plastic surface in the same way as it would fold in the body, a feature that can be difficult for many classes of proteins. Modifying the plastic surface to promote proper folding and better attachment has been the goal of many groups including Dalenyi Biosurfaces Inc. who have developed novel coatings to address this exact issue. These coatings will be validated in the Sidhu lab using well established techniques and proteins (with antibodies isolated previously). Furthermore, coatings for specific classes of proteins well known to be prone to misfolding will be developed and validated thereby expediting antibody discovery.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
412764-2011
Name nom
Sidhu, Sachdev
Department département
Banting and Best Dept of Medical Research
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
25000
Program id
EGP
Program nane en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
5401
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Immunochemistry
Research subject fr
Chimie immunologique
Partie
1
Nb partie
1
Application title
Phage display validation of custom biosurface coated microplates
Keyword
NSERC
Application summary
Antibodies are a natural defense mechanism of animals to foreign proteins entering a body. They are specific to each protein and can be used in medicine to disable proteins of interest in order to treat a variety of diseases including cancer. Traditionally, antibodies to a specific protein have been isolated by injecting animals with the protein of interest and allowing the animal's natural immune system to create antibodies that are recovered by researchers. This can prove cumbersome with little guarantee of recovering a functional antibody; indeed, numerous proteins fail to illicit a functional antibody after months of work for a variety of reasons. In order to circumvent these difficulties we have employed a technology called phage display that uses bacteria to make synthetic antibodies. Once isolated, we can further strengthen the binding and/or specificity of the antibodies to the selected target (protein), a technique not possible with traditional antibody discovery methods. Phage display, in its fastest and most facile form, requires immobilization of the protein onto a plastic surface before incubation of the protein with a library of antibodies. In order for the isolated antibody to recognize the protein within the body, however, the protein must fold on the plastic surface in the same way as it would fold in the body, a feature that can be difficult for many classes of proteins. Modifying the plastic surface to promote proper folding and better attachment has been the goal of many groups including Dalenyi Biosurfaces Inc. who have developed novel coatings to address this exact issue. These coatings will be validated in the Sidhu lab using well established techniques and proteins (with antibodies isolated previously). Furthermore, coatings for specific classes of proteins well known to be prone to misfolding will be developed and validated thereby expediting antibody discovery.